| Filed On | Filing |
|---|---|
| 02 Apr 2026 | 15-12G |
| 26 Mar 2026 | SCHEDULE 13G/A |
| 23 Mar 2026 | POSASR |
| 23 Mar 2026 | S-8 POS |
| 23 Mar 2026 | S-8 POS |
| 23 Mar 2026 | S-8 POS |
| 23 Mar 2026 | S-8 POS |
| 23 Mar 2026 | S-8 POS |
| 23 Mar 2026 | S-8 POS |
| 23 Mar 2026 | S-8 POS |
| 23 Mar 2026 | S-8 POS |
| 23 Mar 2026 | S-8 POS |
| 23 Mar 2026 | S-8 POS |
| 23 Mar 2026 | S-8 POS |
| 23 Mar 2026 | S-8 POS |
| 23 Mar 2026 | S-8 POS |
| 23 Mar 2026 | S-8 POS |
| 23 Mar 2026 | S-8 POS |
| 23 Mar 2026 |
Form 4: Baranick Brian, EVP, GM, Precision Oncology
Received 33,321 shares as a grant or award · Returned 137,990 shares to the issuer · Disposed of 28,063 Restricted Stock Units (Disposition to Issuer) |
| 23 Mar 2026 |
Form 4: Herriott James, SVP, General Counsel & Sec
Returned 69,957 shares to the issuer · Disposed of 3,654 Stock Options (Right to Buy) (Disposition to Issuer) · Disposed of 20,321 Restricted Stock Units (Disposition to Issuer) |
Loading...
